Mark Scott tells Proactive that the name change to Cello Health Group PLC (LON@CLL) highlights the sharpened focus of the group, while the US now accounts for almost half of profits. More acquisitions are likely, he adds, with the infrastructure and firepower in place to handle more expansion in the US and elsewhere. Results in 2017 met forecasts, helped by good performances in healthcare and at software arm Pulsar and all round things are looking good.